The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that it has added Bavarian Nordic’s mpox vaccine to its list of ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition that claims millions of lives each year. Sepsis results from a dysregulated ...

Nxera Pharma and Cancer Research UK are set to present their ongoing Phase 1/2a clinical trial of the cancer immunotherapy drug HTL0039732 at the European Society for Medical Oncology (ESMO) Congress ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, ...

Speed and relevance are crucial in interactions between biopharma companies and healthcare professionals (HCPs). Data from the Digital Health Coalition reveals that only 27% of HCPs find biopharma ...

Eli Lilly and Company has announced promising results from two phase 3 clinical trials, QWINT-1 and QWINT-3, evaluating the efficacy of once-weekly insulin efsitora alfa (efsitora) in adults with type ...

Vivet Therapeutics, a clinical-stage biotech company developing novel gene therapies for rare liver metabolic disorders, has announced that the European Commission has granted Orphan Drug Designation ...